![]() |
English | Español | 中文简体字 | 繁體中文 | Русский | Italiano![]() |
|||||||||||
|
|
||||||||||||
![]() |
Cancer StagingThe severity of a cancer is determined in part by the findings from the biopsy as outlined in the pathology
report. Staging is important for identifying appropriate treatment options for a particular cancer and individual. It is important to note that although
the stage of a cancer is important, the prognosis may be affected by other
factors, such as age of the patient and other health related factors. TNM Staging One common method of staging is the T/N/M system, which identifies three important characteristics of cancer and assigns a level of severity to each of those characteristics to determine an overall degree of severity for the patient's cancer.
Each tumor is assigned a series of identifiers, which include a T, an N and
an M component. Together these labels give insight into the severity of the
cancer. This set of values is then used to establish a simpler, overall stage
for the cancer, which is then described as stage I, II, III, or IV. As would
be expected, a mild T, N and M grading corresponds to a lower stage number and
a less severe cancer, for example a T1, N0, M0 tumor is most likely labeled
as a stage I cancer. This simplified staging method can help physicians and patients make treatment decisions and also gives an indication of the
prognosis. Some types of cancer have their own staging scales that are different from the general classifications used for other cancers. To read about some of these cancer stagings follow the links below. A good source for both patient and healthcare professional information on stagins is the National Comprehensive Cancer Network. Click here for a summary of the Pathology and Cancer Staging sections.
|
|||||||||||
|
||||||||||||
|
||||||||||||